Erratum: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment

Abstract

“The following institutions participated in this study: Fudan University Shanghai Cancer Center; Zhejiang Cancer Hospital; Guangdong General Hospital; Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology; Nanfang Hospital, Southern Medical University; Sun Yat-Sen University Cancer Hospital; West China Hospital, Sichuan… (More)
DOI: 10.1038/srep35509

Topics

Cite this paper

@inproceedings{Du2016ErratumAM, title={Erratum: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment}, author={F. Du and P. Yuan and Z. T. Zhao and Z. Yang and T. Wang and J. D. Zhao and Y. Luo and F. Ma and J. Y. Wang and Y. Fan and R. G. Cai and P. Zhang and Qiyuan Li and Y. M. Song and Baoji Xu}, booktitle={Scientific reports}, year={2016} }